CA
NZ
UK
AU
IND
US
Cheniere Energy, Inc. (NYSE: LNG) disclosed a governance update that adds a new seat to its board and introduces Britt Vitalone as a fresh independent director. The changes were formalized in mid‑July, reflecting the company’s ongoing efforts to strengthen oversight amid a dynamic energy …
ASML (AMS: ASML / NASDAQ: ASML) just did something it almost never does: raised full-year guidance for the second time in a single year, pushing 2026 sales to €43–45 billion from €36–40 billion, with gross margin climbing to 54–56% from 51–53%. The headline reaction …
Pluri Inc. (NASDAQ: PLUR) remains locked in negotiations with the European Investment Bank (EIB) over a €20 million loan repayment deadline, as the biotech firm seeks to avoid potential enforcement actions. The discussions, described as constructive, aim to resolve the loan’s terms before the …
Propanc Biopharma (NASDAQ: PPCB) confirmed a change to its board of directors. Long‑time director Annie Van Broekhoven stepped down, and the company named Carlo Campiciano as her successor.
West Pharmaceutical Services has formalized an updated collaboration with Daikyo Seiko, amending the cross‑license and distribution framework that originally began several years ago. The renewed agreements replace earlier versions and bring the partnership into the current reporting period.
Palvella Therapeutics (NASDAQ: PVLA) disclosed an investor presentation through a regulatory filing on July 14, 2026. The document, submitted to the U.S. Securities and Exchange Commission, serves as a corporate update for current and prospective shareholders. The filing aligns with disclosure requirements under the …
Johnson & Johnson’s upcoming earnings report is set to clarify whether the healthcare giant can extend its recent market momentum beyond sector rotation trends. The results will test investor confidence in the company’s ability to deliver sustained growth through its new product pipeline, potentially …
- Evofem Biosciences has issued a note worth $706,304 with a 12% interest rate. - The note issuance also includes a fee of $2,000. - The company's stock is traded on the OTC market under the symbol EVFM.
Jaguar Health, Inc. (NASDAQ: JAGX) disclosed that its wholly‑owned unit Napo Pharmaceuticals has secured a fresh manufacturing and supply arrangement with Alivus Life Sciences Limited. The deal ensures continued production of crofelemer, the active ingredient in the FDA‑approved drug Mytesi®, and other related products.
Kestra Medical Technologies (NASDAQ: KMTS) has finalized a $200 million senior secured term loan facility with investment funds managed by Pharmakon Advisors. The agreement, disclosed in a regulatory filing, provides a five-year financing structure to support corporate expansion and working capital needs. The facility …
Please wait processing your request...